Halozyme Therapeutics, Inc. (HALO)

NASDAQ: HALO · Real-Time Price · USD

65.20

-0.82 (-1.24%)

At close: Oct 8, 2025, 4:00 PM EDT

65.20

0.00 (0.00%)

After-hours: Oct 8, 2025, 6:21 PM EDT

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
United States Revenue	-	690.46M	Log In	Log In	Log In	Upgrade
Switzerland Revenue	-	212.39M	Log In	Log In	Log In	Upgrade
Belgium Revenue	-	84.01M	Log In	Log In	Log In	Upgrade
Japan Revenue	-	18.94M	Log In	Log In	Log In	Upgrade
Ireland Revenue	-	-	Log In	Log In	Log In	Upgrade
All Other Foreign Countries Revenue (Pre-FY2023)	-	-	Log In	Log In	Log In	Upgrade
All Other Foreign Countries Revenue (Post-FY2022)	-	9.53M	Log In	Log In	Log In	Upgrade
Revenue (Other)	1.18B	-	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.18B	1.02B	Log In	Log In	Log In	Upgrade

Revenue

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	2013 - 2020
Period Ending	Jun '25 Jun 30, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	2013 - 2020
Royalties Revenue	699.31M	570.99M	Log In	Log In	Log In	Upgrade
Sales of Proprietary Products	170.02M	166.62M	Log In	Log In	Log In	Upgrade
Sales of Bulk rHuPH20	101.49M	86.33M	Log In	Log In	Log In	Upgrade
Sales of Device Partnered Products	54.07M	50.54M	Log In	Log In	Log In	Upgrade
Total Net Product Sales	325.57M	303.49M	Log In	Log In	Log In	Upgrade
Revenue Under Collaborative Agreements	153.79M	140.84M	Log In	Log In	Log In	Upgrade
Revenue (Total)	1.18B	1.02B	Log In	Log In	Log In	Upgrade

Updated Jun 30, 2025. Data Source: Fiscal.ai.